Prostate enlargement is promoted by autoimmune inflammation

Prostate enlargement—benign prostatic hyperplasia (BPH)—is fundamentally an inflammatory process that can undergo conversion to malignancy and emerge as prostate cancer. The authors of a study just published in The Journal of Urology offer important evidence that autoimmune phenomena drive prostate inflammation and enlargement.